Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enzalutamide and PSA-TRICOM in non-metastatic castration-sensitive prostate cancer
NCT01875250Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Jul 2013
- Primary completion
- Sep 2019
- Countries
- 1
01
Overview
A Phase 2 trial of PROSTVAC-V/TRICOM in prostate cancer (PCa), sponsored by National Cancer Institute. Started Jul 2013; status: completed.
02
Drugs
PROSTVAC-V/TRICOM
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT01875250.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01875250.